We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.75B
AUM Growth
+$24.7M
Cap. Flow
-$74.5M
Cap. Flow %
-4.25%
Top 10 Hldgs %
27.66%
Holding
275
New
15
Increased
70
Reduced
162
Closed
18

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$10.8M
2
WNS
WNS Holdings
WNS
+$9.49M
3
FN icon
Fabrinet
FN
+$8.56M
4
ADMA icon
ADMA Biologics
ADMA
+$6.59M
5
YOU icon
Clear Secure
YOU
+$5.91M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 23.6%
3 Industrials 20.27%
4 Communication Services 5.79%
5 Consumer Staples 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITM icon
76
SiTime
SITM
$20.7B
$4.96M 0.28%
53,236
-1,590
-3% -$167K
MODN
77
DELISTED
MODEL N, INC.
MODN
$4.93M 0.28%
173,036
-8,211
-5% -$217K
AIN icon
78
Albany International
AIN
$1.73B
$4.89M 0.28%
52,276
-10,830
-17% -$993K
OPRX icon
79
OptimizeRx
OPRX
$129M
$4.88M 0.28%
401,882
+59,141
+17% +$858K
INSM icon
80
Insmed
INSM
$29.4B
$4.87M 0.28%
179,332
-41,938
-19% -$1.17M
PINC
81
DELISTED
Premier
PINC
$4.83M 0.28%
218,409
-8,726
-4% -$189K
PNTG icon
82
Pennant Group
PNTG
$1.38B
$4.73M 0.27%
240,783
+440
+0.2% +$7.41K
ALG icon
83
Alamo Group
ALG
$2.06B
$4.66M 0.27%
20,423
+47
+0.2% +$9.83K
CBZ icon
84
CBIZ
CBZ
$2.95B
$4.63M 0.26%
58,925
-202
-0.3% -$14K
UTMD icon
85
Utah Medical Products
UTMD
$227M
$4.59M 0.26%
64,614
-40,397
-38% -$3.03M
EHC icon
86
Encompass Health
EHC
$12.5B
$4.55M 0.26%
55,111
+7,225
+15% +$529K
ANIP icon
87
ANI Pharmaceuticals
ANIP
$1.72B
$4.48M 0.26%
64,834
-86
-0.1% -$5.19K
TTEK icon
88
Tetra Tech
TTEK
$8.97B
$4.48M 0.26%
121,150
-12,220
-9% -$423K
ELF icon
89
e.l.f. Beauty
ELF
$5.62B
$4.26M 0.24%
21,709
-10,888
-33% -$1.93M
BLBD icon
90
Blue Bird Corp
BLBD
$2.07B
$4.15M 0.24%
+108,355
New +$3.32M
HAE icon
91
Haemonetics
HAE
$3.94B
$4.09M 0.23%
47,864
-9,157
-16% -$719K
HLIT icon
92
Harmonic Inc
HLIT
$1.26B
$4M 0.23%
297,875
+658
+0.2% +$8.4K
CNTY icon
93
Century Casinos
CNTY
$33.8M
$3.91M 0.22%
1,238,446
-10,717
-0.9% -$36.1K
RYTM icon
94
Rhythm Pharmaceuticals
RYTM
$7.95B
$3.89M 0.22%
89,726
+121
+0.1% +$5.29K
PWSC
95
DELISTED
PowerSchool Holdings, Inc.
PWSC
$3.88M 0.22%
182,254
-32,832
-15% -$745K
OR icon
96
OR Royalties Inc
OR
$6.32B
$3.88M 0.22%
236,233
-46,487
-16% -$687K
FVRR icon
97
Fiverr
FVRR
$327M
$3.87M 0.22%
+183,614
New +$4.6M
DORM icon
98
Dorman Products
DORM
$3.95B
$3.83M 0.22%
+39,720
New +$3.42M
ACLS icon
99
Axcelis
ACLS
$4.1B
$3.83M 0.22%
34,317
-1,730
-5% -$206K
ON icon
100
ON Semiconductor
ON
$31.1B
$3.73M 0.21%
50,773
-1,156
-2% -$88.5K

Similar funds

Rice Hall James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Rice Hall James & Associates held 275 positions worth $1.75B, up 1.4% from $1.73B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rice Hall James & Associates withdrew a net $74.5M in Q1 2024, closing 18 positions and reducing 162 holdings. Its most notable exit was PGT, Inc., an estimated $25.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in ADMA Biologics worth $7.96M.

  • Rice Hall James & Associates's largest Q1 2024 buy was ADMA Biologics: 1,206,499 shares worth $7.96M.
  • Rice Hall James & Associates added most to Alkermes in Q1 2024, an estimated $10.8M increase.
  • Rice Hall James & Associates's biggest Q1 2024 reduction was MASONITE INTERNATIONAL CORP, cutting an estimated $10.2M.
  • Rice Hall James & Associates fully exited PGT, Inc. in Q1 2024, selling an estimated $25.4M.
  • Rice Hall James & Associates's ten largest holdings make up 28% of its $1.75B portfolio in Q1 2024.
  • Rice Hall James & Associates opened 15 new positions and closed 18 in Q1 2024.
  • Rice Hall James & Associates's portfolio value rose 1.4% quarter-over-quarter to $1.75B.

Based on Rice Hall James & Associates's 13F filing for Q1 2024, filed 23 Apr 2024.